China Pharma Holdings Stock Momentum Indicators Ultimate Oscillator

CPHI Stock  USD 0.20  0.01  5.26%   
China Pharma momentum indicators tool provides the execution environment for running the Ultimate Oscillator indicator and other technical functions against China Pharma. China Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Ultimate Oscillator indicator function is designed to identify and follow existing trends. Momentum indicators of China Pharma are pattern recognition functions that provide distinct formation on China Pharma potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify First Period, Second Period and Third Period to execute this model.

The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Ultimate Oscillator is a smoothing indicator that uses the weighted average of China Pharma three different time periods to reduce the effects of volatility and false trends of China Pharma Holdings price series.

China Pharma Technical Analysis Modules

Most technical analysis of China Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for China from various momentum indicators to cycle indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About China Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of China Pharma Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of China Pharma Holdings based on widely used predictive technical indicators. In general, we focus on analyzing China Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build China Pharma's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of China Pharma's intrinsic value. In addition to deriving basic predictive indicators for China Pharma, we also check how macroeconomic factors affect China Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.0021050.00187
Price To Sales Ratio0.290.28
Hype
Prediction
LowEstimatedHigh
0.010.207.18
Details
Intrinsic
Valuation
LowRealHigh
0.010.187.16
Details
Naive
Forecast
LowNextHigh
00.227.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.160.220.27
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as China Pharma. Your research has to be compared to or analyzed against China Pharma's peers to derive any actionable benefits. When done correctly, China Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in China Pharma Holdings.

Align your values with your investing style

In addition to having China Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
When determining whether China Pharma Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Pharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Pharma Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Pharma Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Pharma. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.63
Quarterly Revenue Growth
(0.16)
Return On Assets
(0.18)
Return On Equity
(0.75)
The market value of China Pharma Holdings is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Pharma's value that differs from its market value or its book value, called intrinsic value, which is China Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Pharma's market value can be influenced by many factors that don't directly affect China Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.